Area of research
Immunology · Oncology
Research interest
Research interests include CAR-T cell therapy research, Immune Cell Function and Interaction, T-cell and B-cell Immunology, and Cancer Immunotherapy and Biomarkers.
Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis
Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies
Emerging trends in clinical allogeneic CAR cell therapy
Generating allogeneic CAR-NKT cells for off-the-shelf cancer immunotherapy with genetically engineered HSP cells and feeder-free differentiation culture
Multimodal targeting of metastatic renal cell carcinoma via CD70-directed allogeneic CAR-NKT cells
Allogeneic stem cell-engineered EGFRvIII-specific CAR-NKT cells for treating glioblastoma with enhanced efficacy and safety
Clinical technology advances driving in vivo CAR therapy
Protocol to generate allorejection-resistant universal CAR-NKT cells and evaluate their efficacy, mechanism of action, safety, and immunogenicity
Generation of allogeneic CAR-NKT cells from hematopoietic stem and progenitor cells using a clinically guided culture method
Viscoelastic synthetic antigen-presenting cells for augmenting the potency of cancer therapies
Breaking the mold: Unconventional T cells in cancer therapy
Biomimetic cell stimulation with a graphene oxide antigen-presenting platform for developing T cell-based therapies
Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies
Graft-versus-Host Disease Modulation by Innate T Cells
Profiling ovarian cancer tumor and microenvironment during disease progression for cell-based immunotherapy design
Genetic engineering strategies to enhance antitumor reactivity and reduce alloreactivity for allogeneic cell-based cancer therapy
Mucosal-associated invariant T cells for cancer immunotherapy
Targeting Immunosuppressive Tumor-Associated Macrophages Using Innate T Cells for Enhanced Antitumor Reactivity
3D Tumor Spheroid and Organoid to Model Tumor Microenvironment for Cancer Immunotherapy
Tumor-Localized Administration of α-GalCer to Recruit Invariant Natural Killer T Cells and Enhance Their Antitumor Activity against Solid Tumors